We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellular Dynamics International and Roche Palo Alto Enter Agreement to Screen Drug Compounds for Cardiotoxicity

News   Mar 07, 2008

 
Cellular Dynamics International and Roche Palo Alto Enter Agreement to Screen Drug Compounds for Cardiotoxicity
 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Improved Screening Strategies Help Advance Pharmaceutical Discovery

News

A new review in SLAS Discovery explores how improved safety screening strategies and methods are improving the pharmaceutical discovery and development process.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE